Learn More
Medchemexpress LLC CPI-1612 | 2374971-81-8 | 99.8% | 450.53 | 100 MG

Supplier: Medchemexpress LLC HY136285100MG
CPI-1612 is a highly potent, orally active EP300/CBP histone acetyltransferase (HAT) inhibitor. It exhibits an IC50 of 8.1 nM for EP300 HAT and demonstrates anticancer activity. This product is intended for research use only.
- Inhibits full length EP300 with an IC50 of <0.5 nM.
- Inhibits full length CBP with an IC50 of 2.9 nM.
- Reduces H3K18Ac MSD and JEKO-1 cell proliferation.
- Shows tumor growth inhibition in animal models.
- Exhibits high brain penetrance in CD-1 mice.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.